BioRestorative Therapies approves 2025 executive bonuses; CEO bonus $300K, VP $287.5K, CFO $140K

BioRestorative Therapies, Inc.

CEO Lance Alstodt awarded $300K cash bonus and $1.5M in option awards; total 2025 compensation $2.4M.
VP Francisco Silva gets $287.5K bonus plus $1.47M in options; total 2025 comp $2.3M.
CFO Robert Kristal awarded $140K bonus and $318K in options; total 2025 comp $801,750.
All bonuses are discretionary for 2025 services, payable in 2026; total compensation up significantly from 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.